Skip to main content

Scrofuloderma and Miliary Tuberculosis in a Patient Taking Adalimumab

This is a preview of subscription content, access via your institution.

Figure 1


  1. van Zyl L, du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis (Edinb). 2015;95(6):629-38.

  2. Franco-Paredes C, Marcos LA, Henao-Martínez AF, Rodríguez-Morales AJ, Villamil-Gómez WE, Gotuzzo E, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2018;32(1).

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Kuniyuki Aso MD, PhD.

Ethics declarations

Conflict of Interest

The author has declared no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Written consent was obtained from the patient. The Institutional Research Ethics Board does not require board review for a single case report when the patient’s privacy is protected.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Aso, K. Scrofuloderma and Miliary Tuberculosis in a Patient Taking Adalimumab. J GEN INTERN MED (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: